Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health
Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved..
Cardiometabolic diseases are leading causes of mortality in Western countries. Well-established risk factors include host genetics, lifestyle, diet, and the gut microbiome. Moreover, gut bacterial communities and their activities can be altered by bacteriophages (also known simply as phages), bacteria-infecting viruses, making these biological entities key regulators of human cardiometabolic health. The manipulation of bacterial populations by phages enables the possibility of using phages in the treatment of cardiometabolic diseases through phage therapy and fecal viral transplants. First, however, a deeper understanding of the role of the phageome in cardiometabolic diseases is required. In this review, we first introduce the phageome as a component of the gut microbiome and discuss fecal viral transplants and phage therapy in relation to cardiometabolic diseases. We then summarize the current state of phageome research in cardiometabolic diseases and propose how the phageome might indirectly influence cardiometabolic health through gut bacteria and their metabolites.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:43 |
|---|---|
| Enthalten in: |
Cell reports - 43(2024), 2 vom: 27. Feb., Seite 113728 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Kirk, Daniel [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Bacteriophage |
|---|
| Anmerkungen: |
Date Completed 04.03.2024 Date Revised 04.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.celrep.2024.113728 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM367901978 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM367901978 | ||
| 003 | DE-627 | ||
| 005 | 20240304232405.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240202s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.celrep.2024.113728 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1316.xml |
| 035 | |a (DE-627)NLM367901978 | ||
| 035 | |a (NLM)38300802 | ||
| 035 | |a (PII)S2211-1247(24)00056-1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Kirk, Daniel |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Bacteriophages, gut bacteria, and microbial pathways interplay in cardiometabolic health |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 04.03.2024 | ||
| 500 | |a Date Revised 04.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Cardiometabolic diseases are leading causes of mortality in Western countries. Well-established risk factors include host genetics, lifestyle, diet, and the gut microbiome. Moreover, gut bacterial communities and their activities can be altered by bacteriophages (also known simply as phages), bacteria-infecting viruses, making these biological entities key regulators of human cardiometabolic health. The manipulation of bacterial populations by phages enables the possibility of using phages in the treatment of cardiometabolic diseases through phage therapy and fecal viral transplants. First, however, a deeper understanding of the role of the phageome in cardiometabolic diseases is required. In this review, we first introduce the phageome as a component of the gut microbiome and discuss fecal viral transplants and phage therapy in relation to cardiometabolic diseases. We then summarize the current state of phageome research in cardiometabolic diseases and propose how the phageome might indirectly influence cardiometabolic health through gut bacteria and their metabolites | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Review | |
| 650 | 4 | |a CP: Metabolism | |
| 650 | 4 | |a CP: Microbiology | |
| 650 | 4 | |a bacteriophage | |
| 650 | 4 | |a cardiometabolic diseases | |
| 650 | 4 | |a fecal virome transplant | |
| 650 | 4 | |a microbiome | |
| 650 | 4 | |a obesity | |
| 650 | 4 | |a phage therapy | |
| 650 | 4 | |a phageome | |
| 700 | 1 | |a Costeira, Ricardo |e verfasserin |4 aut | |
| 700 | 1 | |a Visconti, Alessia |e verfasserin |4 aut | |
| 700 | 1 | |a Khan Mirzaei, Mohammadali |e verfasserin |4 aut | |
| 700 | 1 | |a Deng, Li |e verfasserin |4 aut | |
| 700 | 1 | |a Valdes, Ana M |e verfasserin |4 aut | |
| 700 | 1 | |a Menni, Cristina |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Cell reports |d 2012 |g 43(2024), 2 vom: 27. Feb., Seite 113728 |w (DE-627)NLM217067492 |x 2211-1247 |7 nnns |
| 773 | 1 | 8 | |g volume:43 |g year:2024 |g number:2 |g day:27 |g month:02 |g pages:113728 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.celrep.2024.113728 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 43 |j 2024 |e 2 |b 27 |c 02 |h 113728 | ||